108 related articles for article (PubMed ID: 28532694)
41. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
Lee MH; Yang HI; Liu J; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; You SL; Wang LY; Chen CJ;
Hepatology; 2013 Aug; 58(2):546-54. PubMed ID: 23504622
[TBL] [Abstract][Full Text] [Related]
42. Characterization of the genotype and integration patterns of hepatitis B virus in early- and late-onset hepatocellular carcinoma.
Yan H; Yang Y; Zhang L; Tang G; Wang Y; Xue G; Zhou W; Sun S
Hepatology; 2015 Jun; 61(6):1821-31. PubMed ID: 25627239
[TBL] [Abstract][Full Text] [Related]
43. High Prevalence of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection in Thailand.
Wanich N; Vilaichone RK; Chotivitayatarakorn P; Siramolpiwat S
Asian Pac J Cancer Prev; 2016; 17(6):2857-60. PubMed ID: 27356702
[TBL] [Abstract][Full Text] [Related]
44. Histological characteristics predisposing to development of hepatocellular carcinoma in patients with chronic hepatitis B.
Lee SH; Chung YH; Kim JA; Jin YJ; Park WH; Choi JG; Lee D; Shim JH; Yu E; Jang MK
J Clin Pathol; 2011 Jul; 64(7):599-604. PubMed ID: 21572113
[TBL] [Abstract][Full Text] [Related]
45. The increasing incidence of hepatocellular carcinoma.
Ince N; Wands JR
N Engl J Med; 1999 Mar; 340(10):798-9. PubMed ID: 10072416
[No Abstract] [Full Text] [Related]
46. Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan.
Tseng TC; Liu CJ; Chen PJ; Lai MY; Lin CL; Kao JH; Chen DS
Liver Int; 2007 Sep; 27(7):983-8. PubMed ID: 17696938
[TBL] [Abstract][Full Text] [Related]
47. Re: hepatocellular carcinoma risk factors and disease burden in a european cohort: a nested case-control study.
Polesel J; Montella M; Dal Maso L; Crispo A; Serraino D; Talamini R
J Natl Cancer Inst; 2012 Nov; 104(21):1681-3; author reply 1683-4. PubMed ID: 22972970
[No Abstract] [Full Text] [Related]
48. The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long-term nucleos(t)ide analogue therapy.
Coffin CS; Rezaeeaval M; Pang JX; Alcantara L; Klein P; Burak KW; Myers RP
Aliment Pharmacol Ther; 2014 Dec; 40(11-12):1262-9. PubMed ID: 25312649
[TBL] [Abstract][Full Text] [Related]
49. Prognosis and predictors of hepatocellular carcinoma in elderly patients infected with hepatitis B virus.
Osawa M; Akuta N; Suzuki F; Fujiyama S; Kawamura Y; Sezaki H; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Suzuki Y; Ikeda K; Kumada H
J Med Virol; 2017 Dec; 89(12):2144-2148. PubMed ID: 28667756
[TBL] [Abstract][Full Text] [Related]
50. Viral hepatitis and hepatocellular carcinoma.
Marrero CR; Marrero JA
Arch Med Res; 2007 Aug; 38(6):612-20. PubMed ID: 17613352
[TBL] [Abstract][Full Text] [Related]
51. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma.
Kew MC
Pathol Biol (Paris); 2010 Aug; 58(4):273-7. PubMed ID: 20378277
[TBL] [Abstract][Full Text] [Related]
52. Temporal trend and risk determinants of hepatocellular carcinoma in chronic hepatitis B patients on entecavir or tenofovir.
Hsu YC; Ho HJ; Lee TY; Huang YT; Wu MS; Lin JT; Wu CY; El-Serag HB
J Viral Hepat; 2018 May; 25(5):543-551. PubMed ID: 29193536
[TBL] [Abstract][Full Text] [Related]
53. The epidemiology of hepatocellular carcinoma.
Johnson PJ
Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):845-9. PubMed ID: 8889448
[TBL] [Abstract][Full Text] [Related]
54. [Hepatocellular carcinoma associated with continuous and discontinuous application of nucleoside analogues in the treatment of chronic hepatitis B].
Duan S; Bao Z; Yuan X; Liu M; Wang L; Xiao M
Zhonghua Gan Zang Bing Za Zhi; 2014 Jun; 22(6):462-4. PubMed ID: 25282732
[No Abstract] [Full Text] [Related]
55. Chronic hepatitis B and hepatocellular carcinoma.
McClune AC; Tong MJ
Clin Liver Dis; 2010 Aug; 14(3):461-76. PubMed ID: 20638025
[TBL] [Abstract][Full Text] [Related]
56. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.
Chien J; Liu J; Lee MH; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; You SL; Yang HI; Chen CJ
J Gastroenterol Hepatol; 2016 Dec; 31(12):1971-1977. PubMed ID: 27118149
[TBL] [Abstract][Full Text] [Related]
57. Consider more about risk scores for predicting hepatocellular carcinoma in patients with chronic hepatitis B.
Liu Y
J Viral Hepat; 2021 Oct; 28(10):1500. PubMed ID: 34216528
[No Abstract] [Full Text] [Related]
58. Hepatocellular carcinoma not related to hepatitis B virus infection among Alaska natives.
Chung YH; Di Bisceglie AM; McMahon BJ; Lanier AP; Harpster A; Alter MJ; Parkinson AJ; Zanis C
Int J Circumpolar Health; 1999 Jul; 58(3):208-13. PubMed ID: 10528471
[TBL] [Abstract][Full Text] [Related]
59. Effect of virological response to entecavir on the development of hepatocellular carcinoma in hepatitis B viral cirrhotic patients: comparison between compensated and decompensated cirrhosis.
Kim SS; Hwang JC; Lim SG; Ahn SJ; Cheong JY; Cho SW
Am J Gastroenterol; 2014 Aug; 109(8):1223-33. PubMed ID: 24890440
[TBL] [Abstract][Full Text] [Related]
60. Hepatocellular carcinoma surveillance at 4- vs. 12-month intervals for patients with chronic viral hepatitis: a randomized study in community.
Wang JH; Chang KC; Kee KM; Chen PF; Yen YH; Tseng PL; Kuo YH; Tsai MC; Hung CH; Chen CH; Tai WC; Tsai LS; Chen SC; Lin SC; Lu SN
Am J Gastroenterol; 2013 Mar; 108(3):416-24. PubMed ID: 23318478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
